公开(公告)号：US20240374571A1

公开(公告)日：2024-11-14

申请号：US18687616

申请日：2022-08-30

Applicant: Novartis AG

Inventor： Emilie CHAPEAU ,  Laurent L'EPICIER-SANSREGRET ,  Tobias SCHMELZLE

IPC: A61K31/416 ,  A61K31/4439 ,  A61K31/497 ,  A61K31/506 ,  A61K31/519 ,  A61K31/5377 ,  A61K31/55 ,  A61P35/00

Abstract: The invention relates to a pharmaceutical combination comprising a TEAD inhibitor in combination with a first and optionally a second therapeutically active agent. The present invention also relates to methods of treating cancer involving administering to a subject in need thereof the TEAD inhibitor in combination with the first and optionally the second therapeutically active agent.